RPS6KA2 and ovarian cancer: In conclusion, the miR-512-3p/RPS6KA2 axis plays a critical role in regulating cisplatin sensitivity in ovarian cancer by coordinately influencing both autophagy and ferroptosis signaling pathway at both in vitro and in vivo levels.